Rankings
▼
Calendar
RAPT FY 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$127M
Net Income
-$117M
EPS (Diluted)
$-24.37
Cash Flow
Operating Cash Flow
-$97M
Free Cash Flow
-$98M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$173M
Total Liabilities
$26M
Stockholders' Equity
$147M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$2M
-100.0%
Gross Profit
$0
$2M
-100.0%
Operating Income
-$127M
-$86M
-48.1%
Net Income
-$117M
-$84M
-39.3%
← Q4 2022
All Quarters
Q1 2023 →